BioSpace

An Insmed takeout by Sanofi would be ‘clear strategic fit’ in respiratory space

If it came to fruition, the rumored deal between Sanofi and Insmed would likely be the year’s largest, with one analyst putting a potential value for the biotech as high as $40 billion.

By BioSpace

1 min read
An Insmed takeout by Sanofi would be ‘clear strategic fit’ in respiratory space
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights